Firsts that Change the Future

What is HB 1802?

Texas House Bill 1802 was the first psychedelic research legislation passed in the United States.
It was the first public funding for psychedelic research since the Controlled Substances Act.
It established the first psilocybin for PTSD clinical trial in the United States.
It created the model for psychedelic advocacy that has been used across the country.

HB 1802, passed in 2021 during the 87th Legislative Session, established a clinical trial for the use of psilocybin to treat PTSD in Veterans. Baylor College of Medicine is conducting the trial in collaboration with HHSC in partnership with a military Veterans hospital or a medical center that provides medical care to Veterans.

The study also includes a literature review of the efficacy and access to psilocybin, MDMA, and ketamine in the United States.

After the passage of HB 1802, Texas emerged as a leader in advancing psychedelic therapies in the US. This legislation paved the way for underserved groups, including Veterans, to access these therapies.